| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | potassium channel activity | 4.71e-06 | 128 | 195 | 9 | GO:0005267 | |
| GeneOntologyMolecularFunction | gated channel activity | KCNMB2 KCNH8 BEST3 CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 KCNE2 TPCN2 GRIK5 PIEZO2 KCNQ4 TMC5 | 5.50e-06 | 334 | 195 | 14 | GO:0022836 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | KCNMB2 KCNH8 CCT8L2 KCNJ4 ABCC8 KCNAB1 KCNE2 GRIK5 SLC9C2 KCNQ4 | 5.87e-06 | 167 | 195 | 10 | GO:0015079 |
| GeneOntologyMolecularFunction | activin receptor activity, type I | 9.04e-06 | 5 | 195 | 3 | GO:0016361 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | KCNMB2 KCNH8 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 KCNE2 TPCN2 GRIK5 PIEZO2 KCNQ4 | 3.44e-05 | 343 | 195 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | KCNMB2 KCNH8 BEST3 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 KCNE2 TPCN2 GRIK5 PIEZO2 KCNQ4 TMC5 | 4.76e-05 | 459 | 195 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | activin receptor activity | 7.38e-05 | 9 | 195 | 3 | GO:0017002 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 SLC29A4 KCNE2 SLC5A10 TPCN2 GRIK5 SLC9C2 PIEZO2 KCNQ4 | 9.46e-05 | 664 | 195 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 BEST3 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 SLC29A4 KCNE2 SLC5A10 TPCN2 GRIK5 SLC9C2 PIEZO2 KCNQ4 TMC5 | 1.03e-04 | 793 | 195 | 20 | GO:0015075 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.85e-04 | 85 | 195 | 6 | GO:0019199 | |
| GeneOntologyMolecularFunction | activin binding | 1.89e-04 | 12 | 195 | 3 | GO:0048185 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | KCNMB2 KCNH8 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 KCNE2 SLC5A10 TPCN2 GRIK5 SLC9C2 KCNQ4 | 2.01e-04 | 465 | 195 | 14 | GO:0046873 |
| GeneOntologyMolecularFunction | channel activity | KCNMB2 KCNH8 BEST3 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 KCNE2 TPCN2 GRIK5 PIEZO2 KCNQ4 TMC5 | 2.10e-04 | 525 | 195 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | KCNMB2 KCNH8 BEST3 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 KCNE2 TPCN2 GRIK5 PIEZO2 KCNQ4 TMC5 | 2.14e-04 | 526 | 195 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 BEST3 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A SLC25A38 KCNAB1 STRA6 SLC29A4 KCNE2 SLC5A10 TPCN2 IPO8 SLC6A16 GRIK5 SLC9C2 SLC22A12 PIEZO2 KCNQ4 TMC5 | 2.19e-04 | 1180 | 195 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 3.36e-04 | 133 | 195 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 4.31e-04 | 182 | 195 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 KCNE2 SLC5A10 TPCN2 GRIK5 SLC9C2 KCNQ4 | 4.55e-04 | 627 | 195 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | peptide receptor activity | 4.58e-04 | 140 | 195 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.58e-04 | 140 | 195 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.63e-04 | 184 | 195 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 4.97e-04 | 102 | 195 | 6 | GO:0005249 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 6.35e-04 | 193 | 195 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 7.26e-04 | 197 | 195 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 7.47e-04 | 152 | 195 | 7 | GO:0022843 | |
| GeneOntologyMolecularFunction | transporter activity | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 BEST3 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A SLC25A38 KCNAB1 STRA6 SLC29A4 KCNE2 SLC5A10 TPCN2 IPO8 SLC6A16 GRIK5 SLC9C2 SLC22A12 PIEZO2 KCNQ4 TMC5 | 8.05e-04 | 1289 | 195 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 9.25e-04 | 20 | 195 | 3 | GO:0004675 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 BEST3 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 KCNE2 SLC5A10 TPCN2 GRIK5 SLC9C2 KCNQ4 | 1.27e-03 | 758 | 195 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TSPAN12 GPR82 ADGRB2 TSHR ACVR1B F2RL2 QRFPR TAS2R13 KISS1R ABCC8 ADGRF4 FGFR2 IL17RB NPR1 DRD2 GPR35 NTSR1 GRIK5 ACVR1C OR9A1P TGFBR1 MST1R RXFP4 IL6R EPHA8 | 1.58e-03 | 1353 | 195 | 25 | GO:0004888 |
| GeneOntologyMolecularFunction | MutSalpha complex binding | 1.93e-03 | 7 | 195 | 2 | GO:0032407 | |
| GeneOntologyMolecularFunction | MutLalpha complex binding | 1.93e-03 | 7 | 195 | 2 | GO:0032405 | |
| GeneOntologyBiologicalProcess | growth | TSHR BCL2L1 ACVR1B SESN1 PRDM11 CYFIP1 FDPS ASPM FGFR2 STRA6 MMP13 PLS1 PHIP IL17RB AKAP6 NPR1 DRD2 DERL2 ACVR1C CYFIP2 TGFBR1 MEGF8 LRP1 KDM2A MAEL C9orf72 CDH1 IL6R SOS1 | 5.96e-06 | 1235 | 196 | 29 | GO:0040007 |
| GeneOntologyBiologicalProcess | neurotransmitter transport | SYN3 LRRK2 NAPA BCL2L1 SYNJ1 ABCC8 SLC29A4 DRD2 SLC6A16 GRIK5 CADPS CADPS2 | 7.36e-06 | 259 | 196 | 12 | GO:0006836 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 BEST3 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 SLC29A4 AKAP6 KCNE2 DRD2 SLC5A10 TPCN2 SLC6A16 GPR35 NTSR1 GRIK5 SLC9C2 IBTK PIEZO2 KCNQ4 PLCH2 TMC5 | 7.44e-06 | 1115 | 196 | 27 | GO:0034220 |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | ATP6V1C1 ATP6V0A1 SYN3 LRRK2 NAPA BCL2L1 CYFIP1 SYNJ1 GRIK5 CADPS C9orf72 CADPS2 | 8.93e-06 | 264 | 196 | 12 | GO:0099504 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 SLC29A4 AKAP6 KCNE2 DRD2 SLC5A10 TPCN2 SLC6A16 GPR35 NTSR1 SLC9C2 IBTK PIEZO2 KCNQ4 PLCH2 | 1.09e-05 | 942 | 196 | 24 | GO:0098655 |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | ATP6V1C1 ATP6V0A1 SYN3 LRRK2 NAPA BCL2L1 CYFIP1 SYNJ1 GRIK5 CADPS LRP1 C9orf72 CADPS2 | 1.30e-05 | 321 | 196 | 13 | GO:0099003 |
| GeneOntologyBiologicalProcess | export from cell | SYN3 LRRK2 NAPA BCL2L1 F2RL2 SNX19 KISS1R SYNJ1 ABCC8 MMP13 SLC29A4 SEL1L KCNE2 EXOC6 DRD2 TPCN2 NTSR1 PORCN GRIK5 ACVR1C RFX3 TXLNA CADPS LRP1 C9orf72 CADPS2 | 3.78e-05 | 1153 | 196 | 26 | GO:0140352 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 BEST3 PKDREJ KLHL3 CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 SLC29A4 AKAP6 KCNE2 DRD2 SLC5A10 TPCN2 SLC6A16 GPR35 NTSR1 GRIK5 SLC9C2 SLC22A12 IBTK PIEZO2 KCNQ4 PLCH2 TMC5 | 4.33e-05 | 1374 | 196 | 29 | GO:0006811 |
| GeneOntologyBiologicalProcess | regulation of growth | TSHR BCL2L1 ACVR1B SESN1 PRDM11 CYFIP1 FDPS FGFR2 PLS1 PHIP IL17RB AKAP6 NPR1 DRD2 DERL2 TGFBR1 MEGF8 LRP1 MAEL CDH1 | 5.39e-05 | 777 | 196 | 20 | GO:0040008 |
| GeneOntologyBiologicalProcess | potassium ion transport | KCNMB2 KCNH8 CCT8L2 KCNJ4 ABCC8 KCNAB1 AKAP6 KCNE2 DRD2 SLC9C2 KCNQ4 | 6.16e-05 | 272 | 196 | 11 | GO:0006813 |
| GeneOntologyBiologicalProcess | cell morphogenesis | HGF NCKAP1 MYO7A LRRK2 BRWD3 CYFIP1 SSH1 NBEAL2 FGFR2 PLS1 PHIP CNTN4 DRD2 CNTNAP1 FRYL ARTN THOC2 CYFIP2 MEGF8 LRP1 MAEL CTNND2 C9orf72 CDH1 SOS1 EPHA8 | 6.75e-05 | 1194 | 196 | 26 | GO:0000902 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 AKAP6 KCNE2 DRD2 SLC5A10 TPCN2 SLC6A16 GPR35 NTSR1 SLC9C2 IBTK KCNQ4 PLCH2 | 6.93e-05 | 922 | 196 | 22 | GO:0098662 |
| GeneOntologyBiologicalProcess | secretion by cell | SYN3 LRRK2 NAPA BCL2L1 F2RL2 SNX19 KISS1R SYNJ1 ABCC8 MMP13 SEL1L EXOC6 DRD2 TPCN2 NTSR1 PORCN GRIK5 ACVR1C RFX3 TXLNA CADPS LRP1 C9orf72 CADPS2 | 7.67e-05 | 1064 | 196 | 24 | GO:0032940 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | KCNMB2 KCNH8 CCT8L2 KCNJ4 ABCC8 KCNAB1 AKAP6 KCNE2 SLC9C2 KCNQ4 | 7.88e-05 | 232 | 196 | 10 | GO:0071805 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 BEST3 PKDREJ CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 AKAP6 KCNE2 DRD2 SLC5A10 TPCN2 SLC6A16 GPR35 NTSR1 SLC9C2 IBTK KCNQ4 PLCH2 | 1.05e-04 | 1017 | 196 | 23 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 PKDREJ KLHL3 CCT8L2 KCNJ4 ABCC8 SCN10A KCNAB1 SLC29A4 AKAP6 KCNE2 DRD2 SLC5A10 TPCN2 SLC6A16 GPR35 NTSR1 SLC9C2 IBTK PIEZO2 KCNQ4 PLCH2 | 1.06e-04 | 1157 | 196 | 25 | GO:0006812 |
| GeneOntologyBiologicalProcess | signal release from synapse | 1.07e-04 | 195 | 196 | 9 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 1.07e-04 | 195 | 196 | 9 | GO:0007269 | |
| GeneOntologyBiologicalProcess | developmental growth | TSHR CYFIP1 FDPS ASPM FGFR2 STRA6 MMP13 PLS1 AKAP6 DRD2 ACVR1C CYFIP2 TGFBR1 MEGF8 LRP1 KDM2A MAEL C9orf72 CDH1 IL6R SOS1 | 1.64e-04 | 911 | 196 | 21 | GO:0048589 |
| GeneOntologyBiologicalProcess | signal release | SYN3 LRRK2 NAPA BCL2L1 F2RL2 SNX19 KISS1R SYNJ1 ABCC8 DRD2 PORCN GRIK5 ACVR1C RFX3 CADPS LRP1 CADPS2 | 1.74e-04 | 653 | 196 | 17 | GO:0023061 |
| GeneOntologyBiologicalProcess | regulation of urine volume | 1.79e-04 | 30 | 196 | 4 | GO:0035809 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 1.95e-04 | 125 | 196 | 7 | GO:0016079 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 2.04e-04 | 31 | 196 | 4 | GO:0016082 | |
| GeneOntologyBiologicalProcess | secretion | SYN3 LRRK2 NAPA BCL2L1 F2RL2 SNX19 KISS1R SYNJ1 ABCC8 MMP13 SEL1L EXOC6 NPR1 DRD2 TPCN2 NTSR1 PORCN GRIK5 ACVR1C RFX3 TXLNA CADPS LRP1 C9orf72 CADPS2 | 2.44e-04 | 1221 | 196 | 25 | GO:0046903 |
| GeneOntologyBiologicalProcess | artery morphogenesis | 2.47e-04 | 92 | 196 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | orbitofrontal cortex development | 2.68e-04 | 3 | 196 | 2 | GO:0021769 | |
| GeneOntologyBiologicalProcess | tight junction disassembly | 2.68e-04 | 3 | 196 | 2 | GO:1905071 | |
| GeneOntologyBiologicalProcess | positive regulation of tight junction disassembly | 2.68e-04 | 3 | 196 | 2 | GO:1905075 | |
| GeneOntologyBiologicalProcess | regulation of tight junction disassembly | 2.68e-04 | 3 | 196 | 2 | GO:1905073 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | KCNMB2 KCNH8 LRRK2 BCL2L1 SSH1 ABCC8 SCN10A AKAP6 KCNE2 DRD2 GPR35 CNTNAP1 NTSR1 GRIK5 PIEZO2 | 3.07e-04 | 559 | 196 | 15 | GO:0042391 |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in determination of left/right asymmetry | 3.53e-04 | 15 | 196 | 3 | GO:0060287 | |
| GeneOntologyBiologicalProcess | positive regulation of urine volume | 3.53e-04 | 15 | 196 | 3 | GO:0035810 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of a nerve | 3.53e-04 | 15 | 196 | 3 | GO:0048755 | |
| GeneOntologyBiologicalProcess | embryonic body morphogenesis | 3.53e-04 | 15 | 196 | 3 | GO:0010172 | |
| GeneOntologyBiologicalProcess | positive regulation of growth | TSHR CYFIP1 FDPS FGFR2 PLS1 AKAP6 DRD2 DERL2 TGFBR1 MEGF8 LRP1 | 4.18e-04 | 339 | 196 | 11 | GO:0045927 |
| GeneOntologyCellularComponent | activin receptor complex | 1.57e-05 | 6 | 195 | 3 | GO:0048179 | |
| GeneOntologyCellularComponent | potassium channel complex | 5.46e-05 | 104 | 195 | 7 | GO:0034705 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | KCNMB2 KCNH8 BEST3 KCNJ4 ABCC8 SCN10A KCNAB1 AKAP6 KCNE2 TPCN2 PORCN GRIK5 KCNQ4 | 5.85e-05 | 378 | 195 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 BEST3 KCNJ4 ABCC8 SCN10A KCNAB1 AKAP6 KCNE2 TPCN2 PORCN GRIK5 KCNQ4 | 1.23e-04 | 523 | 195 | 15 | GO:1902495 |
| GeneOntologyCellularComponent | SCAR complex | 1.65e-04 | 12 | 195 | 3 | GO:0031209 | |
| GeneOntologyCellularComponent | transporter complex | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 BEST3 KCNJ4 ABCC8 SCN10A KCNAB1 AKAP6 KCNE2 TPCN2 PORCN GRIK5 KCNQ4 | 2.12e-04 | 550 | 195 | 15 | GO:1990351 |
| GeneOntologyCellularComponent | presynapse | ATP6V1C1 ATP6V0A1 SYN3 ATR LRRK2 NAPA BCL2L1 CYFIP1 SYNJ1 ABCC8 SCN10A SLC29A4 DRD2 CNTNAP1 NTSR1 GRIK5 CADPS C9orf72 CADPS2 CDH1 | 2.44e-04 | 886 | 195 | 20 | GO:0098793 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 2.85e-04 | 179 | 195 | 8 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 2.85e-04 | 179 | 195 | 8 | GO:0030672 | |
| GeneOntologyCellularComponent | cation channel complex | 3.76e-04 | 235 | 195 | 9 | GO:0034703 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SYN3 LRRK2 ADGRB2 NAPA SYNJ1 KCNJ4 SCN10A DRD2 CNTNAP1 PORCN GRIK5 CADPS LRP1 CTNND2 C9orf72 CADPS2 CDH1 KLHL17 | 6.67e-04 | 817 | 195 | 18 | GO:0098978 |
| GeneOntologyCellularComponent | extrinsic component of organelle membrane | 6.82e-04 | 43 | 195 | 4 | GO:0031312 | |
| GeneOntologyCellularComponent | membrane protein complex | KCNMB2 ATP6V1C1 ATP6V0A1 KCNH8 GPAA1 NAPA BEST3 ACVR1B SYNJ1 KCNJ4 ABCC8 SCN10A KCNAB1 SEL1L AKAP6 KCNE2 DRD2 TPCN2 PORCN GRIK5 ACVR1C TGFBR1 KCNQ4 LRP1 RNF139 CDH1 IL6R | 7.49e-04 | 1498 | 195 | 27 | GO:0098796 |
| GeneOntologyCellularComponent | distal axon | LRRK2 CYFIP1 SSH1 SYNJ1 EXOC6 DRD2 NTSR1 GRIK5 LRP1 C9orf72 CDH1 INPP5J | 8.26e-04 | 435 | 195 | 12 | GO:0150034 |
| GeneOntologyCellularComponent | plasma membrane protein complex | KCNMB2 ACVR1B SYNJ1 KCNJ4 ABCC8 SCN10A KCNAB1 KCNE2 DRD2 PORCN GRIK5 ACVR1C TGFBR1 KCNQ4 LRP1 CDH1 IL6R | 1.13e-03 | 785 | 195 | 17 | GO:0098797 |
| GeneOntologyCellularComponent | receptor complex | TSHR ACVR1B ARNT2 FGFR2 NPR1 DRD2 PORCN GRIK5 ACVR1C LDLR TGFBR1 MST1R LRP1 IL6R | 1.15e-03 | 581 | 195 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | perikaryon | 1.21e-03 | 223 | 195 | 8 | GO:0043204 | |
| GeneOntologyCellularComponent | apical part of cell | ATP6V1C1 MYO7A CA14 F2RL2 ASPM SLC29A4 KCNE2 SLC5A10 LDLR SLC22A12 TGFBR1 LRP1 CDH1 IL6R | 1.38e-03 | 592 | 195 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | extrinsic component of synaptic vesicle membrane | 1.58e-03 | 25 | 195 | 3 | GO:0098850 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 1.63e-03 | 91 | 195 | 5 | GO:0008076 | |
| GeneOntologyCellularComponent | cell surface | SLAMF8 CFH FAM234A TSHR ACVR1B KISS1R FGFR2 IL17RB CDON ALPP KCNE2 NID2 NTSR1 ACVR1C LDLR TGFBR1 MST1R AOC3 LRP1 CDH1 IL6R | 1.68e-03 | 1111 | 195 | 21 | GO:0009986 |
| GeneOntologyCellularComponent | axon | CFH LRRK2 CYFIP1 SSH1 SYNJ1 SCN10A KCNAB1 CNTN4 EXOC6 DRD2 AZIN2 CNTNAP1 NTSR1 GRIK5 LRP1 C9orf72 CDH1 INPP5J | 1.77e-03 | 891 | 195 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | terminal bouton | 2.07e-03 | 96 | 195 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | synaptic vesicle | 2.09e-03 | 300 | 195 | 9 | GO:0008021 | |
| GeneOntologyCellularComponent | Derlin-1 retrotranslocation complex | 2.34e-03 | 8 | 195 | 2 | GO:0036513 | |
| GeneOntologyCellularComponent | plasma membrane raft | 2.60e-03 | 147 | 195 | 6 | GO:0044853 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.66e-03 | 253 | 195 | 8 | GO:0030427 | |
| Domain | GS_dom | 3.69e-05 | 7 | 193 | 3 | IPR003605 | |
| Domain | GS | 3.69e-05 | 7 | 193 | 3 | PS51256 | |
| Domain | TGF_beta_GS | 3.69e-05 | 7 | 193 | 3 | PF08515 | |
| Domain | GS | 3.69e-05 | 7 | 193 | 3 | SM00467 | |
| Domain | Quino_amine_DH_bsu | 6.99e-05 | 22 | 193 | 4 | IPR011044 | |
| Domain | BTB-kelch_protein | 7.83e-05 | 43 | 193 | 5 | IPR017096 | |
| Domain | Kelch_1 | 8.53e-05 | 70 | 193 | 6 | PF01344 | |
| Domain | Kelch_1 | 8.53e-05 | 70 | 193 | 6 | IPR006652 | |
| Domain | Cytoplasmic_FMR1-int | 1.06e-04 | 2 | 193 | 2 | IPR008081 | |
| Domain | CAPS | 1.06e-04 | 2 | 193 | 2 | IPR033227 | |
| Domain | FragX_IP | 1.06e-04 | 2 | 193 | 2 | PF05994 | |
| Domain | Activin_recp | 1.24e-04 | 10 | 193 | 3 | PF01064 | |
| Domain | Activin_recp | 1.24e-04 | 10 | 193 | 3 | IPR000472 | |
| Domain | TGFB_receptor | 2.23e-04 | 12 | 193 | 3 | IPR000333 | |
| Domain | RFX1_trans_act | 3.17e-04 | 3 | 193 | 2 | IPR007668 | |
| Domain | RFX1_trans_act | 3.17e-04 | 3 | 193 | 2 | PF04589 | |
| Domain | Kelch | 3.29e-04 | 58 | 193 | 5 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 3.56e-04 | 59 | 193 | 5 | IPR011043 | |
| Domain | Ldl_recept_b | 3.64e-04 | 14 | 193 | 3 | PF00058 | |
| Domain | LDLRB | 3.64e-04 | 14 | 193 | 3 | PS51120 | |
| Domain | BACK | 3.85e-04 | 60 | 193 | 5 | SM00875 | |
| Domain | BACK | 4.16e-04 | 61 | 193 | 5 | IPR011705 | |
| Domain | BACK | 4.16e-04 | 61 | 193 | 5 | PF07707 | |
| Domain | BTB | 4.28e-04 | 131 | 193 | 7 | PF00651 | |
| Domain | LY | 4.51e-04 | 15 | 193 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.51e-04 | 15 | 193 | 3 | IPR000033 | |
| Domain | ARM-like | 5.19e-04 | 270 | 193 | 10 | IPR011989 | |
| Domain | DUF1394 | 6.29e-04 | 4 | 193 | 2 | IPR009828 | |
| Domain | DUF1394 | 6.29e-04 | 4 | 193 | 2 | PF07159 | |
| Domain | FATC | 1.04e-03 | 5 | 193 | 2 | PF02260 | |
| Domain | DUF1041 | 1.04e-03 | 5 | 193 | 2 | SM01145 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | DPF1 FAM234A ATP6V0A1 GPAA1 TSHR YIF1A KCNJ4 ABCC8 USP4 SETD3 AKR1B1 DRD2 TPCN2 GPR35 CNTNAP1 CYFIP2 PLCH2 RXFP4 CTNND2 | 2.04e-08 | 697 | 197 | 19 | 28298427 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO7A ADGRB2 COMTD1 ELAC2 ADCY7 MDN1 SSH1 SYNJ1 NBEAL2 FGFR2 ABTB2 TRAF7 OFD1 KMT5C NTSR1 FRYL REV3L LDLR DHX30 MST1R MROH1 MEGF8 PRRT4 KLHL17 | 2.05e-08 | 1105 | 197 | 24 | 35748872 |
| Pubmed | NCKAP1 ADGRB2 CYFIP1 SYNJ1 UBE2N KCNJ4 KCNAB1 CNTNAP1 GRIK5 CYFIP2 LRP1 CTNND2 | 2.39e-08 | 251 | 197 | 12 | 27507650 | |
| Pubmed | CFH KLHL2 MBTPS1 BEST3 CA14 ADCY7 HENMT1 MDN1 SSH1 SYNJ1 FDPS FOXO4 ADGRF4 MED27 PLS1 SEL1L AKAP6 SLC5A10 TPCN2 YIPF4 ST3GAL4 REV3L MST1R TIGD2 CADPS2 | 9.56e-08 | 1293 | 197 | 25 | 15342556 | |
| Pubmed | KCNMB2 SMG1 MYO7A FER1L6 PLEKHH1 KLHL3 CYFIP1 MDN1 UBE2N EXOC6 AZIN2 DERL2 REV3L TEFM MEGF8 CTNND2 HELLS | 1.61e-07 | 638 | 197 | 17 | 31182584 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CFH MBTPS1 FAM234A ATP6V0A1 GPAA1 ATR ELAC2 CDON SEL1L TRAF7 NPR1 YIPF4 CNTNAP1 DERL2 RNF213 ST3GAL4 LDLR SPAG5 TGFBR1 MST1R TXNDC15 MEGF8 LRP1 | 3.84e-07 | 1201 | 197 | 23 | 35696571 |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 24474649 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 15294869 | ||
| Pubmed | ATP6V0A1 KCNH8 BCL2L1 ACVR1B GALNT16 KLHL3 MAPK12 SSH1 UBE2N USP4 MMP13 DNAH10 LDLR MAP4K1 LRP1 KDM2A KLHL17 | 1.04e-06 | 730 | 197 | 17 | 34857952 | |
| Pubmed | 1.11e-06 | 183 | 197 | 9 | 23956138 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.37e-06 | 139 | 197 | 8 | 16985003 | |
| Pubmed | 3.54e-06 | 6 | 197 | 3 | 31023188 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | CFH MYO7A ELAC2 CYFIP1 MDN1 NBEAL2 COQ9 ASPM MROH7 USP4 ABTB2 SEL1L KCNE2 USP30 GPR35 FRYL CYFIP2 TTLL11 KDM8 CDH1 ACTL10 | 8.71e-06 | 1242 | 197 | 21 | 30973865 |
| Pubmed | 9.82e-06 | 8 | 197 | 3 | 16845371 | ||
| Pubmed | Abi1 is essential for the formation and activation of a WAVE2 signalling complex. | 2.09e-05 | 10 | 197 | 3 | 15048123 | |
| Pubmed | SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. | 2.09e-05 | 10 | 197 | 3 | 21040848 | |
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 2.86e-05 | 11 | 197 | 3 | 16607638 | |
| Pubmed | 3.06e-05 | 276 | 197 | 9 | 28319085 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 18177725 | ||
| Pubmed | R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. | 3.19e-05 | 2 | 197 | 2 | 19667187 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 17889283 | ||
| Pubmed | Genome-wide association of breast cancer: composite likelihood with imputed genotypes. | 3.19e-05 | 2 | 197 | 2 | 20959865 | |
| Pubmed | Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. | 3.19e-05 | 2 | 197 | 2 | 11971949 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 30335615 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 29549916 | ||
| Pubmed | LRP: role in vascular wall integrity and protection from atherosclerosis. | 3.19e-05 | 2 | 197 | 2 | 12690199 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 34201526 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 26435084 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 21626674 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 23675503 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 28075014 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 28883501 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 35323108 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 22628578 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 27043821 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 22287599 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 29434188 | ||
| Pubmed | CAPS facilitates filling of the rapidly releasable pool of large dense-core vesicles. | 3.19e-05 | 2 | 197 | 2 | 18495893 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 17244893 | ||
| Pubmed | Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition. | 3.19e-05 | 2 | 197 | 2 | 25416817 | |
| Pubmed | Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers. | 3.19e-05 | 2 | 197 | 2 | 23624386 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 34327661 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 10575007 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 25719439 | ||
| Pubmed | Zebrafish Dpr2 inhibits mesoderm induction by promoting degradation of nodal receptors. | 3.19e-05 | 2 | 197 | 2 | 15459392 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 17709443 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 31324746 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 10514495 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 32197071 | ||
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 3.19e-05 | 2 | 197 | 2 | 38128786 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 27794539 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 30804470 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 20131016 | ||
| Pubmed | CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins. | 3.19e-05 | 2 | 197 | 2 | 18022372 | |
| Pubmed | Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. | 3.19e-05 | 2 | 197 | 2 | 29752658 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 37356280 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 9449704 | ||
| Pubmed | Two distinct secretory vesicle-priming steps in adrenal chromaffin cells. | 3.19e-05 | 2 | 197 | 2 | 20855507 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 17505534 | ||
| Pubmed | Arabidopsis GNARLED encodes a NAP125 homolog that positively regulates ARP2/3. | 3.19e-05 | 2 | 197 | 2 | 15296760 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 23588498 | ||
| Pubmed | Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein. | 3.19e-05 | 2 | 197 | 2 | 9820815 | |
| Pubmed | C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. | 3.19e-05 | 2 | 197 | 2 | 24357318 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 25175457 | ||
| Pubmed | Striatal D2 receptors regulate dendritic morphology of medium spiny neurons via Kir2 channels. | 3.19e-05 | 2 | 197 | 2 | 22396414 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 16207888 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 19363480 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 35567753 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 15857609 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 3.51e-05 | 351 | 197 | 10 | 20453000 | |
| Pubmed | 3.79e-05 | 12 | 197 | 3 | 25872870 | ||
| Pubmed | 3.79e-05 | 12 | 197 | 3 | 23342175 | ||
| Pubmed | CFH ATP6V0A1 NAPA BRWD3 PLEKHH1 SYNJ1 AKAP6 CNTN4 CNTNAP1 REV3L INTS8 CBS DHX30 TXNDC15 ARHGEF10 CADPS LRP1 CTNND2 CADPS2 SOS1 | 4.63e-05 | 1285 | 197 | 20 | 35914814 | |
| Pubmed | TBX2 specifies and maintains inner hair and supporting cell fate in the Organ of Corti. | 4.91e-05 | 13 | 197 | 3 | 36494345 | |
| Pubmed | 8.58e-05 | 41 | 197 | 4 | 23676014 | ||
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 8.89e-05 | 79 | 197 | 5 | 12679517 | |
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 23846497 | ||
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 16226102 | ||
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 19667105 | ||
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 21730304 | ||
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 10330134 | ||
| Pubmed | Ciliogenic RFX transcription factors regulate FGF1 gene promoter. | 9.54e-05 | 3 | 197 | 2 | 22415835 | |
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 25421310 | ||
| Pubmed | Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis. | 9.54e-05 | 3 | 197 | 2 | 37120427 | |
| Pubmed | P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway. | 9.54e-05 | 3 | 197 | 2 | 25976617 | |
| Pubmed | RAGE, LDL receptor, and LRP1 expression in the brains of SAMP8. | 9.54e-05 | 3 | 197 | 2 | 19539695 | |
| Pubmed | Drosophila regulatory factor X is necessary for ciliated sensory neuron differentiation. | 9.54e-05 | 3 | 197 | 2 | 12403718 | |
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 23675525 | ||
| Pubmed | Role of LRRK2 in the regulation of dopamine receptor trafficking. | 9.54e-05 | 3 | 197 | 2 | 28582422 | |
| Pubmed | Secretory vesicle priming by CAPS is independent of its SNARE-binding MUN domain. | 9.54e-05 | 3 | 197 | 2 | 25437547 | |
| Pubmed | LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages. | 9.54e-05 | 3 | 197 | 2 | 26061292 | |
| Pubmed | Interplay of RFX transcription factors 1, 2 and 3 in motile ciliogenesis. | 9.54e-05 | 3 | 197 | 2 | 32725242 | |
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 24699825 | ||
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 10871856 | ||
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 25546260 | ||
| Pubmed | TEFM (c17orf42) is necessary for transcription of human mtDNA. | 9.54e-05 | 3 | 197 | 2 | 21278163 | |
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 18990694 | ||
| Pubmed | Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. | 9.54e-05 | 3 | 197 | 2 | 17303763 | |
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 28604766 | ||
| Pubmed | 9.54e-05 | 3 | 197 | 2 | 21342325 | ||
| GeneFamily | Type 1 receptor serine/threonine kinases | 1.84e-05 | 7 | 148 | 3 | 345 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.18e-04 | 134 | 148 | 7 | 861 | |
| GeneFamily | Kelch like|BTB domain containing | 3.79e-04 | 42 | 148 | 4 | 617 | |
| GeneFamily | Peptide receptors | 1.36e-03 | 7 | 148 | 2 | 220 | |
| GeneFamily | Regulatory factor X family | 1.80e-03 | 8 | 148 | 2 | 1153 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-08 | 157 | 197 | 9 | ed9c9feefc06c9536c03bedbc3397a2ee492a78e | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-08 | 157 | 197 | 9 | fddcb24776b9f86e000208bae54541b15b2adefd | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.95e-07 | 169 | 197 | 8 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.50e-06 | 181 | 197 | 8 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 188 | 197 | 8 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 188 | 197 | 8 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 195 | 197 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.82e-06 | 197 | 197 | 8 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.22e-06 | 156 | 197 | 7 | 27590a4d2b419644966f0037c67c761fc275e0aa | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-06 | 161 | 197 | 7 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-06 | 161 | 197 | 7 | 9cfbbcd38ec2e75376bbc26001964b6991ad0e21 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.97e-06 | 162 | 197 | 7 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.30e-06 | 163 | 197 | 7 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.30e-06 | 163 | 197 | 7 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.35e-06 | 166 | 197 | 7 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.35e-06 | 166 | 197 | 7 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.35e-06 | 166 | 197 | 7 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.35e-06 | 166 | 197 | 7 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.18e-05 | 172 | 197 | 7 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 173 | 197 | 7 | 295bfe1efa648173c2d5981025bc61c576baf53f | |
| ToppCell | Healthy_Control-Lymphoid-NK-CD8_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.27e-05 | 174 | 197 | 7 | 5dddb822fa51b4020e4d9318acacd19c726091d6 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-05 | 175 | 197 | 7 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-05 | 184 | 197 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.89e-05 | 185 | 197 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.95e-05 | 186 | 197 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-05 | 187 | 197 | 7 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 188 | 197 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 188 | 197 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 188 | 197 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-05 | 127 | 197 | 6 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-05 | 127 | 197 | 6 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasmablast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-05 | 76 | 197 | 5 | df1c29cf88b1957e210058e172683f78a1eea2bd | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-05 | 190 | 197 | 7 | d541e076137cf7334bdb0ed69db2f9a27c668c65 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-05 | 191 | 197 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 191 | 197 | 7 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.31e-05 | 191 | 197 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.39e-05 | 192 | 197 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.39e-05 | 192 | 197 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.47e-05 | 193 | 197 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.56e-05 | 194 | 197 | 7 | 8a4be91414a2e69dd410aa75791f16008204c9a1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 195 | 197 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-05 | 196 | 197 | 7 | 3e99a367b7d817e1f1221450fcec20ad7a7c7a2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-05 | 196 | 197 | 7 | 1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.73e-05 | 196 | 197 | 7 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.73e-05 | 196 | 197 | 7 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.82e-05 | 197 | 197 | 7 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 197 | 197 | 7 | 1638959d7aecb9fc5285eb7e4a3103ca437989e2 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 197 | 197 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 197 | 197 | 7 | ad6f047d003c08413264f39a30ba0f7639a257cd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.82e-05 | 197 | 197 | 7 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.91e-05 | 198 | 197 | 7 | 53e9ed1b19cb26be58da0f37057caca0cdfaabeb | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.91e-05 | 198 | 197 | 7 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.91e-05 | 198 | 197 | 7 | c4e7512f0e1d115f2be8acae6048eda8b6b640b2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.91e-05 | 198 | 197 | 7 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-05 | 134 | 197 | 6 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 199 | 197 | 7 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 199 | 197 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.01e-05 | 199 | 197 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 199 | 197 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.01e-05 | 199 | 197 | 7 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 3.01e-05 | 199 | 197 | 7 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.11e-05 | 200 | 197 | 7 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.11e-05 | 200 | 197 | 7 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.11e-05 | 200 | 197 | 7 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.33e-05 | 137 | 197 | 6 | ca8fdbe66a854e6283b22179ec9359ea9e86cd8e | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-05 | 150 | 197 | 6 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.38e-05 | 158 | 197 | 6 | 9a6d9b541446a6aa9f8ed040b330dbb5c6447076 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-05 | 158 | 197 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.38e-05 | 158 | 197 | 6 | 2438713d2a7e32c647ab3384237ed614f4ec8fec | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-05 | 158 | 197 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 160 | 197 | 6 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.47e-05 | 162 | 197 | 6 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.50e-05 | 54 | 197 | 4 | 98b31718fa200432cf86b59a52484da101219f96 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.50e-05 | 54 | 197 | 4 | 872e7374dac64be2c8ebe71e88a2ec6814168d89 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 166 | 197 | 6 | f751cbd01d4978ded7755874ab60504f6291afd7 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 168 | 197 | 6 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-04 | 168 | 197 | 6 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 169 | 197 | 6 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-04 | 169 | 197 | 6 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 171 | 197 | 6 | 9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753 | |
| ToppCell | COVID-19_Convalescent-cDC|COVID-19_Convalescent / Disease condition and Cell class | 1.14e-04 | 171 | 197 | 6 | 9ccaa9f1629818b0f63a5d930ee78c01e04cd98d | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 171 | 197 | 6 | db544252f98e073e5bb4bec4a110cd58e6434435 | |
| ToppCell | COVID-19_Convalescent-cDC-|COVID-19_Convalescent / Disease condition and Cell class | 1.14e-04 | 171 | 197 | 6 | fb5fae8b3adafcbb7c5618d887966b418355ed4d | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 172 | 197 | 6 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 174 | 197 | 6 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | LA-04._Ventricular_Cardiomyocyte_I|LA / Chamber and Cluster_Paper | 1.29e-04 | 110 | 197 | 5 | 34dcd1e1e16e8b6088ff9a7a40532e8bd000c121 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.29e-04 | 175 | 197 | 6 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.29e-04 | 175 | 197 | 6 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 176 | 197 | 6 | eddac2ba68d234e3f56f4ca0e11c19bc0e95b6e1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 176 | 197 | 6 | fb718a6b07aa5d56600263280afa530bcb63db42 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 178 | 197 | 6 | cb91558469ae0748106fb0b6d702edb0ff21a884 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 178 | 197 | 6 | 63f5880a5b514e20ef2c07a6a9cb8df34e6cede5 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 178 | 197 | 6 | 82c84f8b8a7e6a3d3be3351b348a37143279c100 | |
| ToppCell | PSB-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-04 | 178 | 197 | 6 | 45bdbb96094c97756e1b6eebd80eadd8472143f2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 179 | 197 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 179 | 197 | 6 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Acta2_(Mural.Acta2Rgs5.Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 113 | 197 | 5 | 3c745f4d975475860e793f304a846b032515b334 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Acta2_(Mural.Acta2Rgs5.Acta2)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 113 | 197 | 5 | 7c5317bda7f13649af4837ca717dfdad74152f8f | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 113 | 197 | 5 | d67022ae14fae91f9f21ebe8c6ab6d8d6d725bc4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-04 | 181 | 197 | 6 | a8e9ea73c24109a5d4d28bc0577cc869ad932a4d | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.30e-06 | 200 | 195 | 11 | 5744_UP | |
| Disease | Carcinoma in situ of stomach | 3.64e-06 | 17 | 189 | 4 | C0154060 | |
| Disease | Benign neoplasm of stomach | 3.64e-06 | 17 | 189 | 4 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.64e-06 | 17 | 189 | 4 | C0496905 | |
| Disease | Stomach Carcinoma | 8.96e-06 | 21 | 189 | 4 | C0699791 | |
| Disease | angina pectoris | 1.67e-05 | 125 | 189 | 7 | EFO_0003913 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 2.96e-05 | 28 | 189 | 4 | DOID:8466 (biomarker_via_orthology) | |
| Disease | collagenase 3 measurement | 4.08e-05 | 2 | 189 | 2 | EFO_0020271 | |
| Disease | Headache | 5.74e-05 | 64 | 189 | 5 | HP_0002315 | |
| Disease | cervical cancer (is_marker_for) | 8.18e-05 | 36 | 189 | 4 | DOID:4362 (is_marker_for) | |
| Disease | t-lymphocyte activation antigen CD86 measurement | 1.22e-04 | 3 | 189 | 2 | EFO_0020762 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 1.22e-04 | 3 | 189 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | endothelial growth factor measurement, hepatocyte growth factor measurement | 1.22e-04 | 3 | 189 | 2 | EFO_0006900, EFO_0006903 | |
| Disease | behavioural inhibitory control measurement | 1.36e-04 | 16 | 189 | 3 | EFO_0008467 | |
| Disease | aldose reductase measurement | 2.43e-04 | 4 | 189 | 2 | EFO_0801364 | |
| Disease | mitogen-activated protein kinase 12 measurement | 2.43e-04 | 4 | 189 | 2 | EFO_0020576 | |
| Disease | Pain, Crushing | 2.76e-04 | 49 | 189 | 4 | C0458259 | |
| Disease | Pain, Splitting | 2.76e-04 | 49 | 189 | 4 | C0458257 | |
| Disease | Pain | 2.76e-04 | 49 | 189 | 4 | C0030193 | |
| Disease | Pain, Migratory | 2.76e-04 | 49 | 189 | 4 | C0751407 | |
| Disease | Suffering, Physical | 2.76e-04 | 49 | 189 | 4 | C0751408 | |
| Disease | Radiating pain | 2.76e-04 | 49 | 189 | 4 | C0234254 | |
| Disease | Pain, Burning | 2.76e-04 | 49 | 189 | 4 | C0234230 | |
| Disease | Ache | 2.76e-04 | 49 | 189 | 4 | C0234238 | |
| Disease | Infiltrating duct carcinoma of female breast | 3.16e-04 | 21 | 189 | 3 | C3165106 | |
| Disease | sciatic neuropathy (is_implicated_in) | 4.03e-04 | 5 | 189 | 2 | DOID:11446 (is_implicated_in) | |
| Disease | thrombospondin type-1 domain-containing protein 1 measurement | 4.03e-04 | 5 | 189 | 2 | EFO_0802131 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.56e-04 | 152 | 189 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | triacylglycerol 56:4 measurement | 4.74e-04 | 24 | 189 | 3 | EFO_0010431 | |
| Disease | Craniofacial Abnormalities | 5.23e-04 | 156 | 189 | 6 | C0376634 | |
| Disease | familial atrial fibrillation | 5.23e-04 | 156 | 189 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 5.23e-04 | 156 | 189 | 6 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 5.23e-04 | 156 | 189 | 6 | C0235480 | |
| Disease | Atrial Fibrillation | 5.98e-04 | 160 | 189 | 6 | C0004238 | |
| Disease | Schizophrenia | SYN3 ADCY7 CYFIP1 EML5 ADGRF4 FGFR2 DRD2 NTSR1 GRIK5 CBS LRP1 CTNND2 C9orf72 CADPS2 IL6R | 5.99e-04 | 883 | 189 | 15 | C0036341 |
| Disease | Fever, response to sulfasalazine | 6.02e-04 | 6 | 189 | 2 | EFO_0008324, HP_0001945 | |
| Disease | Porokeratosis, Disseminated Superficial Actinic | 6.02e-04 | 6 | 189 | 2 | C0265970 | |
| Disease | anxiety disorder (is_implicated_in) | 6.02e-04 | 6 | 189 | 2 | DOID:2030 (is_implicated_in) | |
| Disease | Stomach Neoplasms | 6.93e-04 | 297 | 189 | 8 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 7.40e-04 | 300 | 189 | 8 | C0024623 | |
| Disease | contactin-4 measurement | 8.39e-04 | 7 | 189 | 2 | EFO_0020287 | |
| Disease | atrial natriuretic factor measurement | 8.39e-04 | 7 | 189 | 2 | EFO_0004789 | |
| Disease | immunoglobulin superfamily containing leucine-rich repeat protein 2 measurement | 8.39e-04 | 7 | 189 | 2 | EFO_0021879 | |
| Disease | Parkinsonism, Juvenile | 9.24e-04 | 30 | 189 | 3 | C0752105 | |
| Disease | spontaneous coronary artery dissection | 1.02e-03 | 31 | 189 | 3 | EFO_0010820 | |
| Disease | arteriosclerosis (is_implicated_in) | 1.02e-03 | 31 | 189 | 3 | DOID:2349 (is_implicated_in) | |
| Disease | Ventricular Fibrillation | 1.11e-03 | 8 | 189 | 2 | C0042510 | |
| Disease | lymphatic vessel endothelial hyaluronic acid receptor 1 measurement | 1.11e-03 | 8 | 189 | 2 | EFO_0020539 | |
| Disease | Squamous cell carcinoma of lung | 1.12e-03 | 32 | 189 | 3 | C0149782 | |
| Disease | Endometrial Carcinoma | 1.19e-03 | 72 | 189 | 4 | C0476089 | |
| Disease | stomach cancer (is_implicated_in) | 1.19e-03 | 72 | 189 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | t-cell surface glycoprotein CD5 measurement | 1.43e-03 | 9 | 189 | 2 | EFO_0803134 | |
| Disease | platelet endothelial cell adhesion molecule measurement | 1.43e-03 | 9 | 189 | 2 | EFO_0010598 | |
| Disease | gout | 1.70e-03 | 196 | 189 | 6 | EFO_0004274 | |
| Disease | Secreted frizzled-related protein 3 measurement | 1.78e-03 | 10 | 189 | 2 | EFO_0008277 | |
| Disease | multimerin-2 measurement | 1.78e-03 | 10 | 189 | 2 | EFO_0801809 | |
| Disease | systolic blood pressure, self reported educational attainment | 1.78e-03 | 10 | 189 | 2 | EFO_0004784, EFO_0006335 | |
| Disease | transverse temporal cortex volume measurement | 1.78e-03 | 10 | 189 | 2 | EFO_0010336 | |
| Disease | Nonsyndromic Deafness | 1.85e-03 | 81 | 189 | 4 | C3711374 | |
| Disease | Moyamoya disease | 2.15e-03 | 40 | 189 | 3 | MONDO_0016820 | |
| Disease | neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, obsolete_red blood cell distribution width, basophil count, platelet count, eosinophil count | 2.16e-03 | 11 | 189 | 2 | EFO_0004305, EFO_0004308, EFO_0004309, EFO_0004526, EFO_0004528, EFO_0004584, EFO_0004833, EFO_0004842, EFO_0005090, EFO_0005091, EFO_0005192 | |
| Disease | colon cancer (implicated_via_orthology) | 2.16e-03 | 11 | 189 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | GASTRIC CANCER | 2.16e-03 | 11 | 189 | 2 | 613659 | |
| Disease | PR domain zinc finger protein 1 measurement | 2.16e-03 | 11 | 189 | 2 | EFO_0801904 | |
| Disease | Gastric cancer | 2.16e-03 | 11 | 189 | 2 | cv:C0024623 | |
| Disease | Neoplasm of stomach | 2.16e-03 | 11 | 189 | 2 | cv:C0038356 | |
| Disease | spontaneous preterm birth, parental genotype effect measurement | 2.16e-03 | 11 | 189 | 2 | EFO_0005939, EFO_0006917 | |
| Disease | Hyperhomocysteinemia | 2.16e-03 | 11 | 189 | 2 | C0598608 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.19e-03 | 206 | 189 | 6 | C0152013 | |
| Disease | Parkinson Disease | 2.20e-03 | 85 | 189 | 4 | C0030567 | |
| Disease | stomach cancer (is_marker_for) | 2.26e-03 | 142 | 189 | 5 | DOID:10534 (is_marker_for) | |
| Disease | high grade glioma (is_marker_for) | 2.47e-03 | 42 | 189 | 3 | DOID:3070 (is_marker_for) | |
| Disease | interferon alpha measurement | 2.58e-03 | 12 | 189 | 2 | EFO_0006517 | |
| Disease | stomach carcinoma (is_implicated_in) | 2.58e-03 | 12 | 189 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | hepatocyte growth factor measurement | 2.82e-03 | 44 | 189 | 3 | EFO_0006903 | |
| Disease | Hereditary Diffuse Gastric Cancer | 2.92e-03 | 293 | 189 | 7 | C1708349 | |
| Disease | Malignant neoplasm of salivary gland | 3.01e-03 | 45 | 189 | 3 | C0220636 | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 3.01e-03 | 45 | 189 | 3 | EFO_0803319 | |
| Disease | tumor necrosis factor ligand superfamily member 8 measurement | 3.04e-03 | 13 | 189 | 2 | EFO_0010592 | |
| Disease | Salivary Gland Neoplasms | 3.41e-03 | 47 | 189 | 3 | C0036095 | |
| Disease | metabolite measurement | GPAA1 SYN3 MAPK12 FDPS PNP REV3L SLC22A12 BCO1 NBAS DPY19L2P2 | 3.43e-03 | 560 | 189 | 10 | EFO_0004725 |
| Disease | Parkinson's disease (implicated_via_orthology) | 3.48e-03 | 157 | 189 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 3.53e-03 | 14 | 189 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | diabetic neuropathy (is_implicated_in) | 3.53e-03 | 14 | 189 | 2 | DOID:9743 (is_implicated_in) | |
| Disease | Alzheimer disease, APOE carrier status | 3.69e-03 | 98 | 189 | 4 | EFO_0007659, MONDO_0004975 | |
| Disease | complement factor H-related protein 4 measurement | 3.84e-03 | 49 | 189 | 3 | EFO_0600091 | |
| Disease | Down syndrome (implicated_via_orthology) | 4.06e-03 | 15 | 189 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | interferon gamma measurement | 4.30e-03 | 51 | 189 | 3 | EFO_0008165 | |
| Disease | depressive disorder (biomarker_via_orthology) | 4.54e-03 | 52 | 189 | 3 | DOID:1596 (biomarker_via_orthology) | |
| Disease | corpus callosum posterior volume measurement | 4.54e-03 | 52 | 189 | 3 | EFO_0010298 | |
| Disease | Romano-Ward Syndrome | 4.62e-03 | 16 | 189 | 2 | C0035828 | |
| Disease | cathepsin L1 measurement | 4.62e-03 | 16 | 189 | 2 | EFO_0010619 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 4.62e-03 | 16 | 189 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | parental longevity | 4.76e-03 | 494 | 189 | 9 | EFO_0007796 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 5.04e-03 | 107 | 189 | 4 | EFO_0004614, EFO_0004615 | |
| Disease | interleukin-1 beta measurement | 5.05e-03 | 54 | 189 | 3 | EFO_0004812 | |
| Disease | body mass index, osteoarthritis | 5.05e-03 | 54 | 189 | 3 | EFO_0004340, MONDO_0005178 | |
| Disease | prostate carcinoma | HGF BCL2L1 SESN1 MAGEF1 DDX10 FGFR2 AKR1B1 PHIP TPCN2 RNF213 RFX3 KDM2A SOS1 | 5.06e-03 | 891 | 189 | 13 | EFO_0001663 |
| Disease | aortic measurement | 5.73e-03 | 251 | 189 | 6 | EFO_0020865 | |
| Disease | Malignant neoplasm of endometrium | 5.84e-03 | 18 | 189 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 5.84e-03 | 18 | 189 | 2 | C0346191 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AIETARAWTRLYAMN | 136 | P61088 | |
| QAIETARAWTRLYAM | 136 | Q5JXB2 | |
| DLQSLMTEMNRYRSW | 206 | Q8N1M1 | |
| TEAWQSYLAVIGRMR | 1016 | O60241 | |
| PASQRMWRIDYSAAV | 76 | Q9H0X4 | |
| SFQRRWITRAMYQEC | 221 | Q5JWF8 | |
| SRVMSSQRYLLKWSV | 686 | O15013 | |
| GTWMRYNLQSALRSA | 1006 | P78357 | |
| MVRFWSEYFTTDRSL | 246 | P22760 | |
| ERSWFREAEIYQTVM | 241 | P36896 | |
| ITYAMSRVAWEALRR | 406 | Q96A70 | |
| QFTVNMTAAVRTYRW | 306 | Q92782 | |
| TSEQYDSLLRQMWER | 71 | O00178 | |
| VWSRVVVTEISYMRH | 426 | Q8IZF3 | |
| SWFREAEIYQTVMLR | 231 | Q8NER5 | |
| YRTWIESLSRCAMNN | 706 | Q8IYW2 | |
| IWMLTVLASADASRY | 746 | Q8IWV2 | |
| VLVSRIAAWMATYLN | 161 | Q07817 | |
| VTMVAWDRYDTTVIT | 426 | Q6RI45 | |
| ENRFYRRISALMWEV | 1196 | Q6RI45 | |
| YVDSPALTNIWMART | 31 | O95567 | |
| REIMENYNIALRWTA | 1171 | P08603 | |
| SVRMTRYLESWGAAR | 481 | P51828 | |
| NESITLDWMFRYSLT | 626 | P16066 | |
| ATRLRSRWLTYFMAV | 1066 | Q7L2E3 | |
| QVLNSMWQYRDLRSL | 1011 | Q9UQB3 | |
| RAACVIQSYWRMRQD | 1561 | Q8IZT6 | |
| MTTLLSYNRNWRVCA | 286 | P15121 | |
| MARGFSWERYQLAVT | 621 | Q16853 | |
| VLSVMYRFRTKNREW | 396 | Q9HBZ2 | |
| LTYIRNTKRTAEVWM | 361 | Q8N428 | |
| VMLSSVLEWYRHRAL | 726 | Q68CQ1 | |
| QYTNRRAFTMLGVVW | 156 | Q96P65 | |
| MAVLLYNRWAIRTIV | 141 | Q75QN2 | |
| DAVEVSTWRRCYTMQ | 171 | Q9NV88 | |
| STWRRCYTMQEVNSA | 176 | Q9NV88 | |
| ARMVASRITNYPTAW | 601 | O75665 | |
| RYMADIFTTCVDTRW | 41 | P48050 | |
| TAIWRLYGRSTMALQ | 426 | Q9UJX4 | |
| DRILWVQAMYRATGQ | 611 | Q9ULU8 | |
| VMLYTWRSCSRAIPQ | 81 | Q7L576 | |
| RTVDSETWYFMVNVT | 111 | P21802 | |
| RTVSMLEYFINRSWE | 386 | Q96K12 | |
| KNAMAERWESRIYAS | 661 | Q8IVT2 | |
| LMWYKDSRTVTESRL | 476 | O60500 | |
| MNELWRATGEVRYQT | 141 | P51606 | |
| KARMSWDRESTEIRY | 51 | Q9NRZ9 | |
| ASVEMYDLRRDRWTA | 441 | Q8N239 | |
| WTNMAISSVAEFRRT | 3116 | Q9NU22 | |
| GITLLRSYMQSVWTE | 66 | Q9Y691 | |
| SWIAISRYATLMQKD | 111 | Q96P67 | |
| IRSLLDVAMWDYSSN | 266 | Q96JY0 | |
| LIYMRGNSAREAQVW | 176 | Q9HAY2 | |
| VIFSDWYNTSVMRKV | 721 | Q14703 | |
| WLERTMRSVGLEVYT | 91 | O43292 | |
| VRRLMFCYISDEQWT | 321 | P30989 | |
| SIMYSTRKRSAQLWL | 161 | Q86Y97 | |
| TVLWTREAVYTMGLN | 296 | Q9P2D0 | |
| IMDSSLTRRGQICWY | 171 | P14324 | |
| RWSAMEIMEAYSVAR | 241 | Q14722 | |
| IYWTDVTTQGSMIRR | 3071 | Q07954 | |
| TRYEAVSFMDVNSTW | 191 | Q5T4W7 | |
| VSFMDVNSTWRTVDR | 196 | Q5T4W7 | |
| DYSILMNVSWVLRAD | 61 | Q9NRM6 | |
| SRYTDEEWSQTLMTV | 241 | Q8N371 | |
| IQAAWRLYSTDMSRA | 346 | P56696 | |
| VWQLMRRYTLNVLSD | 496 | Q14651 | |
| RLTLAQIYEWMVRTV | 121 | P98177 | |
| EYSIWSNRIVRVMPA | 451 | P45452 | |
| GMLWEARASQIRYSV | 21 | Q9Y5G4 | |
| MSRVALESLYRLLWV | 351 | O94915 | |
| LMSRYVESWRVGDTA | 151 | Q6IPT4 | |
| EAAMLWLEYNTESRS | 196 | Q8IY47 | |
| RYSVSERRWTQMLAG | 1541 | Q7Z7M0 | |
| ATLTAMSVDRWYVTV | 131 | Q969F8 | |
| YMRVASVQQVGWSLL | 71 | Q5S007 | |
| RRIFITYMDNWRQNT | 16 | Q9Y6J6 | |
| TRTNIGWMVSLRYRN | 501 | P14210 | |
| SYMNVTWIRIPSETR | 436 | Q8TE49 | |
| VYSSWVTDNILAMAR | 81 | A2A3K4 | |
| VVVRSFMTWLRSYIK | 261 | Q6P2C8 | |
| VMLYTWRSCSRAIPQ | 81 | Q96F07 | |
| YLVSTTVDRMSHVLW | 471 | Q8NDA8 | |
| QWTETRIYMTNLAVA | 51 | Q9HC97 | |
| QRYSVSRWEVFMTHL | 1691 | A2RRP1 | |
| VTRAYTDELWNMALS | 356 | Q8TAG9 | |
| MRLDWFRLQAYTSVS | 486 | Q9Y2A7 | |
| ITAAYVEMRREAWAS | 581 | P33993 | |
| ANAVTLWMLFFRTRS | 111 | O00254 | |
| RYNIIMNSSTFIWVI | 131 | Q8NGU1 | |
| LAIDHIRRTMYWTDS | 1191 | Q14112 | |
| ARYVWNRTELMQASL | 266 | P05187 | |
| GTMVRWLRAYESAVS | 236 | Q9H237 | |
| LNWVARLEMTQNSYR | 1881 | Q13535 | |
| TRMEFQTWALYVANR | 186 | Q5T8I9 | |
| SYAIRDSRQMVWVLS | 11 | Q9NZH7 | |
| RYRAERSKTFTTWMV | 256 | P08887 | |
| AYDTRTDRWHVVASM | 361 | Q6TDP4 | |
| EVWMSVFRYLSRREL | 896 | Q9Y2K7 | |
| ERPYWNMTNRDVISS | 836 | P29322 | |
| VEYKRMRTSNWLVAA | 756 | Q4KMG0 | |
| DSRLWQYLLSRSMRE | 51 | Q86VU5 | |
| SSVRYWMAFNIERAC | 256 | Q92819 | |
| DSVRNYMTKFLSDRW | 376 | P35520 | |
| QDRILWVQAMYRATG | 576 | Q86UW7 | |
| ATNEWIYVADMSTRR | 466 | Q9UH77 | |
| TDFNWYTRRAMLAAI | 236 | O75208 | |
| VRRRWEVMSKVYAVA | 246 | A6NC97 | |
| VTNVRWTYDDSMLVT | 1241 | Q05BV3 | |
| WQVERESISRLMQNY | 46 | Q13206 | |
| YSSKRRVTVMISIVW | 146 | P14416 | |
| GQAFTIMLVYVWSRR | 121 | Q9GZP9 | |
| REIGVWYSNRTLAMN | 386 | Q16478 | |
| LWTVFYRRSQISMEQ | 226 | Q9ULX7 | |
| RRFSQYMLWVTESEP | 4306 | Q8IVF4 | |
| GRRLVLTWSYLQMAV | 171 | Q96S37 | |
| QRYSLTQWVDRNMRS | 381 | Q96BU1 | |
| AASATMRAQWTYSLR | 16 | Q99445 | |
| YDRTMRQRALSTWKQ | 166 | P00491 | |
| FMEQKITYRIWRDTA | 516 | P12830 | |
| YMRSELTAFWRATSE | 331 | Q96LT7 | |
| MADSRRVIIASWYRT | 1 | Q6ZN68 | |
| ITVQSRDAAWYQLLM | 966 | O15397 | |
| RTTWVYSINNVLMSL | 541 | Q92918 | |
| FWLTRVTAQATVLMY | 241 | Q8WU17 | |
| IWMLSNNRRVAYARI | 721 | Q2WGJ9 | |
| YAWVNRSSMTFLTRQ | 316 | Q9Y3I0 | |
| LITALSVARYWVVAM | 131 | Q8TDU9 | |
| LDRYERNTTWNFSMS | 156 | Q9NYV9 | |
| VAMTERYRLWVDSCS | 326 | O14994 | |
| VDLVTYITRFQWDMA | 96 | P21283 | |
| ETMAVSWAYGARRFL | 581 | Q9GZN6 | |
| VDTSMLRRAIWNYIH | 396 | Q9Y6P5 | |
| RSMQLDYTTWTALLS | 646 | Q96R06 | |
| TSQSVKRRIMWHIDY | 401 | Q6IEE7 | |
| QLVTRFQEVFRSMWS | 416 | O43426 | |
| ERGRWSERLMTAYNS | 551 | Q9UBV2 | |
| WSFYSSMVIRDLTLR | 616 | P48378 | |
| WSFYSSMVIRDLTLR | 601 | P48380 | |
| AVYVWIVRSSLQAVM | 326 | Q9NTG1 | |
| RIVLLMHRWYLSSTE | 36 | Q8IV61 | |
| SSIPSYDWMRRVTQR | 121 | Q8IV61 | |
| RWKLSSAETYSRMRL | 1826 | Q6ZNJ1 | |
| DETKANWMRYVVISR | 211 | Q9NQV5 | |
| WRVTQSYARSTAVMS | 2311 | Q96Q15 | |
| VTYFINWIDEIMRLT | 311 | A8MTI9 | |
| YEDYRWAVSSVMTRQ | 241 | Q86TU7 | |
| VLVVMVWYSISREDR | 16 | Q11206 | |
| YWMALRNRVSAVDEL | 1341 | Q149N8 | |
| QARSWMEIIYLSEVL | 316 | Q96SF2 | |
| DRRAYAVWVSEVMLQ | 121 | Q9UIF7 | |
| QSDRWSLMRGIYSSS | 196 | Q96QE5 | |
| RAIVMRYSAEWKSTV | 121 | P41252 | |
| FVDILTNWYVRMNRR | 726 | P41252 | |
| YDSISRLDQWLTTML | 266 | P54920 | |
| NWMAALISLQYRSTL | 536 | Q07889 | |
| RRTLMAAMAWTVYEE | 281 | Q96DW6 | |
| AMVATWRVLLSALYN | 526 | Q9BX79 | |
| SWFREAEIYQTVMLR | 241 | P36897 | |
| RLESAWADRVRYMVV | 96 | Q8WYL5 | |
| WMRVAITYAEHRRSL | 426 | Q8N961 | |
| TAANRWLEVRMEYIG | 1241 | Q09428 | |
| WLRMTSERVRDLTYS | 76 | Q13023 | |
| ATAYIRRMSWASCLA | 261 | Q9HAY6 | |
| AMSSYTVAGRNVLRW | 36 | Q9BYT8 | |
| VVRYRMETVFARSSW | 756 | Q15735 | |
| QRCMDTRTYTWLGAL | 681 | Q63HN8 | |
| TVLDAIYEVSRAWNM | 361 | Q4W5G0 | |
| YIDITRRWNSMTLDQ | 686 | Q8NHH1 | |
| SMSYRGAIIQVFWRL | 351 | Q5GH73 | |
| STLAMDWDSETRRLY | 736 | Q13107 | |
| WTSSALMYFIVRSLR | 236 | O95070 | |
| MLETVTRWHSDRATY | 1046 | Q8NI27 | |
| ASVLVDSRYQQWMER | 346 | Q9BQ52 | |
| VSSLMWEVRYIEHNT | 1221 | Q8WWQ0 | |
| LWRIMRNEVALTNYT | 2466 | O60673 | |
| NSSSTLFTMDIWRRL | 386 | A0PJK1 | |
| RLMTQDSWERLYQQT | 351 | Q9Y5Y9 | |
| EVARTWVTGLRYLMA | 141 | O75038 | |
| FIMYATIRTESIRWL | 336 | Q96J42 | |
| SRRFWMMAIVYTEVA | 1961 | Q9H5I5 | |
| VFSASYDRSLRVWSM | 616 | Q6Q0C0 | |
| TIANYLVWRMVYSRI | 361 | P78562 | |
| YQPRRSTVTWDTALM | 146 | C9JH25 | |
| NISEITYSWRRETTM | 156 | Q9P0V8 | |
| ISVLAVSAWMRDYLN | 26 | O95859 | |
| VSAWMRDYLNNVLTL | 31 | O95859 | |
| IQMIIRDFVLSWYRS | 106 | Q92543 | |
| WESRIYAVATSGMRL | 421 | Q9ULM0 | |
| VRPMFTYNWTEETLR | 481 | Q93050 | |
| VLRMYRWQISSFEEQ | 146 | Q70CQ3 | |
| RYVVARVIWADMLSI | 346 | Q7RTT9 | |
| RVIWADMLSIAVTYF | 351 | Q7RTT9 | |
| IYDVSTYMRTRSWLI | 556 | Q5TAH2 | |
| SMISLYGQFRVVSWI | 126 | Q9BSR8 | |
| QLLTRFSAYMVAWVV | 611 | Q6UXY8 | |
| VKWMALESLQTYRFT | 1251 | Q04912 | |
| SINHRVDASSMWLYR | 61 | Q8NHX9 | |
| MYRSRWESSNKALLE | 431 | P40222 | |
| TLERWYAITFAMRLD | 516 | P16473 | |
| ATTNEWTYIAEMSTR | 471 | O95198 | |
| FGNVTAIIQRMYSRW | 466 | Q96L42 | |
| VASNRIYWSDLSQRM | 436 | P01130 | |
| RQADSEMTGYVVTRW | 176 | P53778 | |
| RLWAVLTVQAYARGM | 836 | Q13402 |